Fed. Cir.

United Therapeutics Corporation v. Liquidia Technologies, Inc., No. 24-1658 (Fed. Cir. Oct. 10, 2024)

General / Procedural

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 24-1658
Decided: October 10, 2024
Judge: Per curiam
Document: Order on Motion
Length: 2 pages

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit UNITED THERAPEUTICS CORPORATION,

Plaintiff-Appellant

LIQUIDIA TECHNOLOGIES, INC.,

Defendant-Appellee

2024-1658

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00755-RGA, Judge Richard G. Andrews.

ON MOTION

Before PROST, HUGHES, and CUNNINGHAM, Circuit Judges.

PER CURIAM.

O R D E R

United Therapeutics Corporation moves to dismiss the above-captioned appeal pursuant to Fed. R. App. P. 42(b) with each side to bear its own costs. Upon consideration thereof,

22 UNITED THERAPEUTICS CORPORATION v.

LIQUIDIA TECHNOLOGIES, INC. IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

October 10, 2024 Date ISSUED AS A MANDATE: October 10, 2024

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

United Therapeutics Corporation v. Liquidia Technologies, Inc., No. 24-1658 (Fed. Cir. Oct. 10, 2024).

Record ID: CAFC-24-1658-20241010
Permalink: https://patentcasewatch.com/opinions/CAFC-24-1658-20241010

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error